Levonorgestrel-releasing intrauterine system (52 mg)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Levonorgestrel-releasing intrauterine system (52 mg), covering 2024-05-14 to 2024-05-14. Get the full timeline:
Most recent: Clinical Trial Update: Study of a Levonorgestrel 52 mg Intrauterine System for the Treatment of Heavy Menstrual Bleeding [Phase 3]